Xarelto Side Effects “Greatly” Increase Risk Of Brain Bleeds: Study
A new study warns that Xarelto may carry three times the risk of brain bleeds when compared to aspirin.…
«
»
A new study warns that Xarelto may carry three times the risk of brain bleeds when compared to aspirin.…
A hearing today will determine whether an appeals court could hear arguments indicating that Xarelto lawsuits are preempted by federal law.…
A new study warns that not only is Xarelto no better than aspirin at preventing recurring strokes, but it also carries a higher risk of major bleeding injuries.…
The release of the highly anticipated Xarelto reversal agent, AndexXa, will be limited to only 40 to 50 hospitals until at least next year, due to concerns the FDA has over the manufacturing process, Portolo Pharmaceuticals CEO told investors.…
A new reversal agent has been approved for Xarelto and Eliquis but will only continue to be approved if postmarketing studies find no problems.…
A jury in Pennsylvania issued a defense verdict in the latest Xarelto bleeding injury lawsuit to go to trial.…
The FDA has granted full approval for the Pradaxa reversal agent, Praxbind, following positive results from phase III clinical trials.…
The FDA is calling for clinical trials before it will approve the long-delayed Xarelto and Eliquis reversal agent, AndexXa.…
A federal judge has ordered case specific discovery for 1,200 Xarelto lawsuits, in what is likely a preparation for the cases to be remanded for individual trial dates.…
A new study finds that aspirin and Xarelto have similar effectiveness at preventing blood clots and similar bleeding risks following hip and knee replacement surgery.…